Brind.

Samara Ferguson's career history reveals she worked at Amgen, GSK, and UCB for over 20 years, culminating in a VP appointment to lead Pricing and Market Access.

1 report, 1 independent Updated Jul 3

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Amgen GSK UCB

Keep exploring

The entities involved

Amgen
American multinational biopharmaceutical company
- Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
- Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
GSK
British multinational pharmaceutical and biotechnology company
- Clement Fourny joins Biodextris as CEO, a company that originated as a GSK development center.Mon 15:26
- GSK acquired Sierra Oncology.Mon 14:28
UCB
biopharmaceutical company headquartered in Brussels, Belgium

Nothing else this week.

Related events

GSK and Amgen are major biopharma players.Sep 8

Coverage

Newest first; wire copies grouped

Jul 3PR NewswirePharmaVentures Appoints Samara Ferguson as Vice President to Lead Pricing and Market Access Team LONDON, July 3, 2025 /PRNewswire/ -- PharmaVentures is pleased to announce the appointment of Samara F